Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. COLPRONE (médrogestone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

COLPRONE (médrogestone)

Medicine - Posted on Oct 14 2025
Active substance (DCI)
  • médrogestone
history (5)
  • 9/24/25

    MEDICINAL PRODUCTS INDICATED IN HORMONAL REPLACEMENT THERAPY FOR THE MENOPAUSE (estradiol, estriol, tibolone, cyproterone acetate, dydrogesterone, levonorgestrel, medrogestone, medroxyprogesterone, norethisterone acetate, progesterone)

    Summary of opinion Favourable opinion for maintenance of reimbursement in: “Hormone replacement therapy (HRT) for oestrogen ...
    CAV :
    54321
    icône flèche
  • 1/15/25

    COLPRONE (medrogestone) - gynecological

    Summary of opinion Favourable opinion for reimbursement only: “when the therapeutic alternatives have failed or are contrain...
    CAV :
    54321
    icône flèche
  • 2/3/16

    COLPRONE (médrogestone)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 5/28/14

    COLPRONE

    -
    icône flèche
  • 1/21/09

    COLPRONE (médrogestone)

    COLPRONE (médrogestone)
    icône flèche
Technical information
ATC code
  • G03DB03
Manufacturer
NEURAXPHARM
Presentation

COLPRONE 5 mg, comprimé (code CIS : 69346531)
2 plaquette(s) thermoformée(s) PVC-aluminium de 10 comprimé(s) (CIP : 34009 313 086 1 4)

All our publications
    Drug therapy Menopause, andropause

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
aa1bbhWwxE8unms6